Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review-Reference-Cited by-同舟云学术

Safety profile of ocrelizumab for the treatment of multiple sclerosis: a systematic review

Published:2020-08-31 Issue:9 Volume:19 Page:1069-1094
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ng Huah Shin¹^ORCID,Rosenbult Constanza Luzon²,Tremlett Helen¹^ORCID

Affiliation:

1. Department of Medicine, Division of Neurology and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada

2. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1807002

Reference114 articles.

1. Multiple sclerosis: diagnosis and the management of acute relapses

2. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts

3. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

4. The prevalence of MS in the United States

5. Multiple Sclerosis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-CD20 therapies for pediatric-onset multiple sclerosis: A systematic review;Multiple Sclerosis and Related Disorders;2024-11

2. The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran;Expert Review of Pharmacoeconomics & Outcomes Research;2024-08-08

3. Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60;Journal of Neurology, Neurosurgery & Psychiatry;2024-03-07

4. Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis;Neurology;2024-02-13

5. Ocrelizumab Kullanan Multipl Skleroz Hastalarında Hepatit B Virüsü Serolojisi;Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi;2023-11-20